265 related articles for article (PubMed ID: 30651599)
1. Mono-ADP-ribosylation of H3R117 traps 5mC hydroxylase TET1 to impair demethylation of tumor suppressor gene TFPI2.
Li M; Tang Y; Li Q; Xiao M; Yang Y; Wang Y
Oncogene; 2019 May; 38(18):3488-3503. PubMed ID: 30651599
[TBL] [Abstract][Full Text] [Related]
2. Transcriptome sequencing analysis of mono‑ADP‑ribosylation in colorectal cancer cells.
Zhang NN; Lin T; Xiao M; Li QS; Li X; Yang L; Wang CL; Wang YL
Oncol Rep; 2020 May; 43(5):1413-1428. PubMed ID: 32323815
[TBL] [Abstract][Full Text] [Related]
3. Mono-ADP-ribosylation of histone 3 at arginine-117 promotes proliferation through its interaction with P300.
Ling F; Tang Y; Li M; Li QS; Li X; Yang L; Zhao W; Jin CC; Zeng Z; Liu C; Wu CF; Chen WW; Lin X; Wang YL; Threadgill MD
Oncotarget; 2017 Sep; 8(42):72773-72787. PubMed ID: 29069825
[TBL] [Abstract][Full Text] [Related]
4. TET1 exerts its anti-tumor functions via demethylating DACT2 and SFRP2 to antagonize Wnt/β-catenin signaling pathway in nasopharyngeal carcinoma cells.
Fan J; Zhang Y; Mu J; He X; Shao B; Zhou D; Peng W; Tang J; Jiang Y; Ren G; Xiang T
Clin Epigenetics; 2018 Aug; 10(1):103. PubMed ID: 30075814
[TBL] [Abstract][Full Text] [Related]
5. Putative promoters within gene bodies control exon expression via TET1-mediated H3K36 methylation.
Ma L; Muhammad T; Wang H; Du G; Sakhawat A; Wei Y; Ali Khan A; Cong X; Huang Y
J Cell Physiol; 2020 Oct; 235(10):6711-6724. PubMed ID: 31994732
[TBL] [Abstract][Full Text] [Related]
6. GADD45A binds R-loops and recruits TET1 to CpG island promoters.
Arab K; Karaulanov E; Musheev M; Trnka P; Schäfer A; Grummt I; Niehrs C
Nat Genet; 2019 Feb; 51(2):217-223. PubMed ID: 30617255
[TBL] [Abstract][Full Text] [Related]
7. Loss of TET1 facilitates DLD1 colon cancer cell migration via H3K27me3-mediated down-regulation of E-cadherin.
Zhou Z; Zhang HS; Liu Y; Zhang ZG; Du GY; Li H; Yu XY; Huang YH
J Cell Physiol; 2018 Feb; 233(2):1359-1369. PubMed ID: 28513825
[TBL] [Abstract][Full Text] [Related]
8. TET1 inhibits gastric cancer growth and metastasis by PTEN demethylation and re-expression.
Pei YF; Tao R; Li JF; Su LP; Yu BQ; Wu XY; Yan M; Gu QL; Zhu ZG; Liu BY
Oncotarget; 2016 May; 7(21):31322-35. PubMed ID: 27121319
[TBL] [Abstract][Full Text] [Related]
9. DNMT3A and TET1 cooperate to regulate promoter epigenetic landscapes in mouse embryonic stem cells.
Gu T; Lin X; Cullen SM; Luo M; Jeong M; Estecio M; Shen J; Hardikar S; Sun D; Su J; Rux D; Guzman A; Lee M; Qi LS; Chen JJ; Kyba M; Huang Y; Chen T; Li W; Goodell MA
Genome Biol; 2018 Jul; 19(1):88. PubMed ID: 30001199
[TBL] [Abstract][Full Text] [Related]
10. 3,6-Dihydroxyflavone regulates microRNA-34a through DNA methylation.
Peng X; Chang H; Chen J; Zhang Q; Yu X; Mi M
BMC Cancer; 2017 Sep; 17(1):619. PubMed ID: 28870206
[TBL] [Abstract][Full Text] [Related]
11. ERK/c-Jun Recruits Tet1 to Induce Zta Expression and Epstein-Barr Virus Reactivation through DNA Demethylation.
Zhang W; Han D; Wan P; Pan P; Cao Y; Liu Y; Wu K; Wu J
Sci Rep; 2016 Oct; 6():34543. PubMed ID: 27708396
[TBL] [Abstract][Full Text] [Related]
12. Hypermethylation of ITGA4, TFPI2 and VIMENTIN promoters is increased in inflamed colon tissue: putative risk markers for colitis-associated cancer.
Gerecke C; Scholtka B; Löwenstein Y; Fait I; Gottschalk U; Rogoll D; Melcher R; Kleuser B
J Cancer Res Clin Oncol; 2015 Dec; 141(12):2097-107. PubMed ID: 25902909
[TBL] [Abstract][Full Text] [Related]
13. TET1 upregulation drives cancer cell growth through aberrant enhancer hydroxymethylation of HMGA2 in hepatocellular carcinoma.
Shirai K; Nagae G; Seki M; Kudo Y; Kamio A; Hayashi A; Okabe A; Ota S; Tsutsumi S; Fujita T; Yamamoto S; Nakaki R; Kanki Y; Osawa T; Midorikawa Y; Tateishi K; Ichinose M; Aburatani H
Cancer Sci; 2021 Jul; 112(7):2855-2869. PubMed ID: 33970549
[TBL] [Abstract][Full Text] [Related]
14. Poly(ADP-ribosyl)ation is involved in the epigenetic control of TET1 gene transcription.
Ciccarone F; Valentini E; Bacalini MG; Zampieri M; Calabrese R; Guastafierro T; Mariano G; Reale A; Franceschi C; Caiafa P
Oncotarget; 2014 Nov; 5(21):10356-67. PubMed ID: 24939750
[TBL] [Abstract][Full Text] [Related]
15. miR-646/TET1 mediated demethylation of IRX1 promoter upregulates HIST2H2BE and promotes the progression of invasive ductal carcinoma.
He B; Chen J; Song W; Bai Y
Genomics; 2021 May; 113(3):1469-1481. PubMed ID: 33667646
[TBL] [Abstract][Full Text] [Related]
16. Targeted DNA demethylation of the ZNF334 promoter inhibits colorectal cancer growth.
Yang B; Tang H; Wang N; Gu J; Wang Q
Cell Death Dis; 2023 Mar; 14(3):210. PubMed ID: 36966142
[TBL] [Abstract][Full Text] [Related]
17. CRISPR-dCas9 mediated TET1 targeting for selective DNA demethylation at BRCA1 promoter.
Choudhury SR; Cui Y; Lubecka K; Stefanska B; Irudayaraj J
Oncotarget; 2016 Jul; 7(29):46545-46556. PubMed ID: 27356740
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic inactivation of the CpG demethylase TET1 as a DNA methylation feedback loop in human cancers.
Li L; Li C; Mao H; Du Z; Chan WY; Murray P; Luo B; Chan AT; Mok TS; Chan FK; Ambinder RF; Tao Q
Sci Rep; 2016 May; 6():26591. PubMed ID: 27225590
[TBL] [Abstract][Full Text] [Related]
19. Association of TET1 expression with colorectal cancer progression.
Tian Y; Pan F; Sun X; Gan M; Lin A; Zhang D; Zhu Y; Lai M
Scand J Gastroenterol; 2017 Mar; 52(3):312-320. PubMed ID: 27846738
[TBL] [Abstract][Full Text] [Related]
20. Relation between carcinogenesis, chromatin structure and poly(ADP-ribosylation) (review).
Boulikas T
Anticancer Res; 1991; 11(2):489-527. PubMed ID: 1905900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
